Guelrud M, Mujica C, Jaen D, Plaz J, Arias J
Department of Medicine, Hospital General del Oeste, Caracas, Venezuela.
Gastrointest Endosc. 1994 Jul-Aug;40(4):428-36. doi: 10.1016/s0016-5107(94)70205-5.
ERCP was performed in 51 patients, aged 1 to 18 years, as part of diagnostic evaluation for recurrent pancreatitis without obvious cause or as therapeutic intervention. ERCP was successful in 50 patients (98%). Thirty-four patients (68%) had anatomic findings indicating a possible cause of recurrent pancreatitis. Three patients (6%) had findings suggestive of sphincter of Oddi dysfunction. Eighteen of the 37 patients (49%) with ductal abnormalities underwent endoscopic therapy, with a favorable outcome in 15 (83%). Eleven patients were treated surgically, and 8 of these patients (73%) improved symptomatically. Eight patients received no treatment, and 6 of them (67%) had recurrent bouts of clinical pancreatitis. One mild case of pancreatitis (1.9%) occurred after ERCP, and 3 mild cases followed endoscopic therapy. In conclusion, ERCP is a relatively safe technique that produces opacification of the desired ductal system with a high degree of accuracy and provides useful information in the evaluation of children with idiopathic recurrent pancreatitis. These data suggest that endoscopic pancreatic therapy may result in symptomatic improvement, eliminating the need for surgery in selected children. Furthermore, the study demonstrates that manipulation of the pancreatic duct is comparatively safe and less hazardous than formerly believed.
对51例年龄在1至18岁的患者进行了内镜逆行胰胆管造影(ERCP),作为对无明显病因的复发性胰腺炎进行诊断评估或治疗干预的一部分。50例患者(98%)ERCP操作成功。34例患者(68%)有解剖学发现提示复发性胰腺炎的可能病因。3例患者(6%)有提示Oddi括约肌功能障碍的发现。37例有导管异常的患者中,18例(49%)接受了内镜治疗,15例(83%)治疗效果良好。11例患者接受了手术治疗,其中8例(73%)症状改善。8例患者未接受治疗,其中6例(67%)出现复发性临床胰腺炎。ERCP术后发生1例轻度胰腺炎(1.9%),内镜治疗后发生3例轻度胰腺炎。总之,ERCP是一种相对安全的技术,能高度准确地使所需的导管系统显影,并为评估特发性复发性胰腺炎患儿提供有用信息。这些数据表明,内镜下胰腺治疗可能会改善症状,使部分患儿无需进行手术。此外,该研究表明,胰管操作相对安全,危险性比以前认为的要小。